Pain Therapeutics, Inc. (Now Cassava Sciences) Granted U.S. Patent #11,385,221 Alzheimer's disease assay in a living patient
Benzinga · 07/12/2022 10:28
Share
Listen to the news
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=4315&f=G&l=50&d=PTXT&p=87&S1=20220712&OS=20220712&RS=20220712
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
Share your ideas here…
All Comments
Related News
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 04/12 18:47
Cassava Sciences Completes Interim Safety Review Of Oral Simufilam On-Going Phase 3 Trials
Benzinga · 03/25 13:14
(SAVA) - Analyzing Cassava Sciences's Short Interest
Benzinga · 03/21 16:30
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2024 Webull. All Rights Reserved